Technical advances have led to the identification..
The 2011 Earle I. Mack – PCF young Investigator Award (second year)
2011 Rebecca and Nathan Milikowsky – PCF young Investigator Award (third year)
Timothy Yap, BSc (Hons), MBBS, MRCP:
The Institute of Cancer Research, The Royal Marsden Hospital
Johann De Bono, MD, PhD
The first medical treatment for metastatic prostate..
Kexin Xu, PhD:
Dana-Farber Cancer Institute, Harvard University
Myles Brown, MD
Understanding the molecules and mechanisms that contribute..
Andreas Varkaris, MD:
The University of Texas MD Anderson Cancer Center
Gary Gallick, PhD and Christopher Logothetis, MD
One of the challenges in prostate cancer..
Barry Taylor, PhD:
University of California, San Fransisco
Charles Sawyers, MD and Chris Sander, PhD
Dr. Srivastava is studying malignant cells from..
Abhishek Srivastava, MD:
University of Michigan
Ashutosh Tewari, MD, PhD
For prostate cancer patients at higher risk..
Timothy Showalter, MD:
University of Virginia
Adam Dicker, MD, PhD and Theresa Hyslop, PhD
It is unclear why prostate cancer selectively..
Yusuke Shiozawa, MD, PhD:
Russell Taichman, DMD
Dr. Roychowdhury works to underline and identify..
Sameek Roychowdhury, MD, PhD:
The Ohio State University
Arul Chinnaiyan, MD, PhD and Ken Pienta, MD
The success of next-generation androgen receptor (AR)..
Dana Rathkopf, MD:
Memorial Sloan-Kettering Cancer Center
Howard Scher and MD Neal Rosen, MD, PhD
A critical unmet need for prostate cancer..
Antoinette Perry, PhD:
Trinity College Dublin – Institute of Molecular Medicine
William Watson, PhD and Donal Hollywood, MD PhD
The Gleason score (derived from the microscopic..
Kathryn L. Penney, ScD:
Harvard Medical School
Massimo Loda, MD and Meir J. Stampfer, MD, DrPH
PTEN (phosphatase and tensin homologue on chromosome..
Tamara Lotan, MD:
Johns Hopkins University
Angelo DeMarzo, MD, PhD and Elizabeth Platz, ScD
Circulating Tumor Cells (CTCs) detach from metastatic..
Richard Lee, MD, PhD:
Massachusetts General Hospital Cancer Center
Matthew R. Smith, MD, PhD
T-cells are a type of fighter blood..
Jihyun Lee, PhD:
University of Pennsylvania
Carl June, MD
To address the challenges of resistance to..
Maria Karlou, PhD:
University of Athens
Christopher Logothetis, MD
Dr. Joshu and colleagues previously observed that..
Corinne Joshu, PhD:
Elizabeth Platz, ScD and Angelo DeMarzo, MD, PhD
Genomic rearrangements that lead to the juxtaposition..
Michael Haffner, MD:
Srinivasan Yegnasubramanian, MD, PhD
The 2011 Bonnie Pfeifer Evans – PCF Young Investigator Award (second year)
The 2011 Todd Boehly – PCF Young Investigator Award
Andrew Goldstein, PhD:
University of California, Los Angeles
Owen Witte, MD
The landscape of therapeutic options for men..
Matthew Cooperberg, MD:
University of California, San Francisco
Peter Caroll, MD and Charles Ryan, MD
A subset of prostate cancer cases (~10%)..
Yu Chen, MD, PhD:
Howard Scher, MD and Charles Sawyers, MD
More than 50% of prostate cancers have..
The 2011 Cayre Family Foundation – PCF Young Investigator Award (second year)
The 2011 Robert Kraft – PCF Young Investigator Award (third year)
John Chadwick Brenner, MSc, PhD:
Arul Chinnaiyan, MD, PhD
Dr. Christopher Barbieri, under the mentorship of..
Christopher Barbieri, MD, PhD:
Weill Cornell Medical College
Mark Rubin, MD
Dr. Bajor, under the mentorship of Dr...
David Bajor, MD:
Robert Vonderheide, MD, DPhil and Carl June, MD
In previous studies, Dr. Joshi Alumkal has..
Joshi Alumkal, MD:
Oregon Health & Science University Knight Cancer Institute
Joe Gray, PhD and Tomasz Beer, MD